CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Clover Health Investments, Corp. /De quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2020 to Q4 2024.
  • Clover Health Investments, Corp. /De Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2024 was $320M, a 0.15% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $320M -$482K -0.15% Dec 31, 2024 10-K 2025-03-03
Q4 2023 $320M +$26.1M +8.86% Dec 31, 2023 10-K 2025-03-03
Q4 2022 $294M +$86.6M +41.7% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $208M +$55.3M +36.3% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $152M Dec 31, 2020 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.